John Morgan FCMA, CGMA (Secretary) |
 John is a Fellow of the Chartered Institute of Management Accountants and has extensive experience in company management and corporate compliance. Formerly Finance Director of a multi-national company and Company Secretary of a LSE quoted company. He also worked as a Management Consultant to a number of companies, including medical research. Email |
Jonathan Cooke |
 Professor Jonathan Cooke has spent over 30 years in the NHS as a senior clinician including the position of Director of Research and Development at the University Hospital of South Manchester. He is visiting Professor, Division of Infectious Diseases, Department of Medicine, Imperial College London and Honorary Professor, Faculty of Medical and Human Sciences, University of Manchester.He has an interest in antimicrobial resistance and is a Member of the Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) and Chair of Antimicrobial Stewardship Committee as well as Advisor to the World Health Organisation European Office. He was a Member of the DH Clostridium difficile Guidelines Working Party. He is author to over 150 peer reviewed publications and reviews and chapters of standard textbooks and has presented over 200 international and national keynote presentations and lectures at major conferences and has received a number of national and international |
John Wood Collins |
 John joins the board from April 2013, is an economist who has spent all his working life in the oil and gas industry.After graduation from the LSE John joined BP and worked in the UK and N. America. After a spell in investment analysis he joined the US consulting firm Arthur D Little and worked in Europe and N Africa. In 1995 he set up his own firm to provide consultancy services on a range of commercial issues. He now primarily works as an expert witness in dispute resolution and international arbitration in the global gas industry. |
Peter J Folkman |
 After graduating from Oxford University he went to study in the USA for an MBA at the Wharton School of the University of Pennsylvania. From there he worked for two American high tech companies before joining the venture capital group 3i plc. He left 3i in 1989 to set up his own venture capital company, North of England Ventures.He was a member of the Council of the British Venture Capital Association. Until the establishment of the new university, Mr Folkman served on the Council of the Victoria University of Manchester and was Chair of The Manchester Federal School of Business and Management. He has held a number of non-executive positions including Chair of the Manchester Science Parks, the Partnership Board of NOWGEN, a centre for genetics in healthcare and was a Non Executive Director of the University Hospital of South Manchester. |
Dr Caroline Pankhurst BSc PhD BDS MSC MRCPath |
 Caroline is a dentist and wasa Clinical Senior Lecturer in Oral Microbiology at King’s College London Dental Institute. Now she is actively involved in postgraduate dental education and training in dental microbiology and oral medicine. She contributes the chapter “Treatment of oropharyngeal candidiasis” to BMJ Clinical Evidence. |
Phillip Oxnam (Chairman) |
 Financial consultant and investment advisor for GS Management S.A. based in Geneva. He is a graduate of the Wharton Business School, University of Pennsylvania and holds a B.A. in management and marketing from Webster University, Geneva. |
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish